Tirzepatide

Price range: $54.99 through $97.99

Tirzepatide is a research-use-only peptide commonly referenced in studies involving GIP
and GLP-1 receptor signaling, metabolic pathway analysis, glucose-regulation
biomarkers, insulin-response models, and energy-balance research.

Secure checkout. Available card and bank-payment options are confirmed at checkout.

Add to Wishlist
Add to Wishlist
SKU: N/A Categories: , Tags: , , , Product ID: 1672

Research catalog profile

Tirzepatide

Tirzepatide is a research-use-only peptide commonly referenced in studies involving GIP
and GLP-1 receptor signaling, metabolic pathway analysis, glucose-regulation
biomarkers, insulin-response models, and energy-balance research.

Catalog reference Product ID 1672
Catalog classification ,
Strength 10mg / 30mg
Intended context Research use only
Research topics

Use the product selector above to confirm the exact strength and configuration before adding this catalog item to your order.

Quality documentation

Review documentation for Tirzepatide

Available laboratory documentation is organized in the Kanaklyx COA library. Before relying on a report, confirm that the compound name, labeled strength, and lot or batch identifier match the product supplied.

Review COA Library

Match these details

  • Compound name
  • Labeled strength
  • Lot or batch identifier
  • Laboratory and report date

Only use documentation that clearly corresponds to the item and batch being reviewed.

Description

Tirzepatide is a research-use-only peptide compound commonly studied in laboratory and
clinical-research settings involving dual incretin pathway analysis, including GIP receptor and
GLP-1 receptor signaling.

It is often referenced in exploratory research related to metabolic-signaling models,
glucose-regulation biomarkers, insulin-response pathway analysis, appetite-regulation research
models, and energy-balance pathway studies.

This compound is intended strictly for laboratory and research applications. It is not intended for
human or animal consumption, administration, diagnosis, treatment, prevention, or cure of any
disease.

Sources & References

Tirzepatide Once Weekly for the Treatment of Obesity

2022 • PMID: 35658024 • DOI: 10.1056/NEJMoa2206038

View Source →

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

2021 • PMID: 34170647 • DOI: 10.1056/NEJMoa2107519

View Source →

Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction

2021 • PMID: 36050763 • DOI: 10.1186/s12933-022-01604-7

View Source →

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

2025 • PMID: 40353578 • DOI: 10.1056/NEJMoa2416394

View Source →

Additional information

Strength

10mg, 30mg

Tirzepatide
$54.99 $97.99Price range: $54.99 through $97.99